Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 27717035.
- Also identified by DOI 10.1002/lary.26191.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Objective tinnitus associated with eyelid closure is a rare clinical entity with only a few reported cases. This association previously was identified as forced eyelid closure syndrome (FECS) and involves an aberrant neural reflex between cranial nerve VII (activating the orbicularis oculi muscle) and cranial nerve V (activating the tensor tympani muscle). We present a 52-year-old Caucasian female with a 2-month history of FECS who was successfully treated with intrapalatal botulinum toxin, with full resolution of her objective tinnitus symptoms. This is the first reported use of botulinum toxin in FECS. Laryngoscope, 127:1199-1201, 2017.
Medical subject headings
- Botulinum Toxins, Type A
- Neuromuscular Agents
- Tinnitus